Curavit Partners With 1nHealth
Curavit Clinical Research announced that it is partnering with 1nHealth. 1nHealth integrates with Curavit's DCT platform, which will aim to speed trial enrollment and improve retention. Curavit and 1nHealth's first collaboration is for Lark Health's trial of an investigational digital therapeutic for chronic cardiovascular disease.
Read more about the partnership here.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
